Work

Haematology

Year: 2008
Type: article
Abstract: Haematology is the study of blood. An introduction to the subject helps to form a firm foundation on which to build an understanding of the science of blood transfusion technology. Being aware of the nature of blood, its composition and its role in the maintenance of health are of value in better addressing the transfusion needs of patients. By the end of this section, the student should be able to describe the following in simple terms: Haemopoiesis Circulatory system Composition and functions of blood plasma red blood cells (erythrocytes) white blood cells (leucocytes) platelets (thrombocytes) Red cell abnormalities leading to chronic anaemia Haemostasis and clotting factors Coagulation defects Haemorrhage and shock Haemopoiesis is the production of blood cells, which in normal healthy adults occurs in the bone marrow and the lymphatic system. (During fetal life, haemopoietic tissue is found in the liver and spleen.) Because all blood cells have a limited lifespan, ongoing replacement of cells that are no longer viable is needed. This happens by division and maturation of precursor cells, mainly in the bone marrow. Mature cells are released into the bloodstream where they circulate and continue to age until they are no longer functional, at which time they are withdrawn from the bloodstream, broken down and the elements either reused or excreted. The specific blood cells that are produced and eventually released into the bloodstream are the red cells or erythrocytes, the various types of white cells or leucocytes and the platelets or thrombocytes. All these formed elements, as the cells are called, originate from common ancestor stem cells that after many cell divisions in the bone marrow result in the mature blood cells that are found in the circulation. The precursor cells are known as blast cells, e.g. the precursor lymphocyte is called a lymphoblast. Normal peripheral blood contains mature cells that do not undergo further division. Figure 1·1 shows a simplified process of haemopoiesis. Arrows indicate cell development in the direction of maturation. Mature erythrocytes and thrombocytes are non-nucleated. Haemopoiesis. Erythropoiesis describes the production of red blood cells. Red cells contain haemoglobin, which is needed for the transportation of oxygen in the bloodstream to all parts of the body. Throughout fetal life, fetal haemoglobin F (HbF) is produced by maturing red cells. It is only after birth that adult haemoglobin A (HbA) predominates. Anaemia is the word used to describe in broad terms, a state of red cell deficiency, either in quantity or quality. An erythropoietic stimulus or trigger is needed for the body to initiate the production of new red cells, to maintain the balance between red cell production and red cell loss. Erythropoiesis is dramatically increased when there is a substantial loss of blood. However, a very gradual yet regular loss of red cells over a long period of time may not result in adequate compensation and an individual could gradually become anaemic without signs or symptoms until the haemoglobin level is dangerously low. The major factor controlling the rate of red cell production is the oxygen content of the blood. A low blood-oxygen level leads to low tissue oxygen, a condition called hypoxia. Hypoxia is the strongest stimulus for erythropoiesis, as seen in the compensated erythropoiesis occurring in individuals living at high altitudes. There is less oxygen in the air at higher altitudes so inhabitants in such areas need more red cells to attach sufficient oxygen than individuals living at sea level, where oxygen in the air is in greater supply. Hypoxia does not have a direct control on the bone marrow but causes the release of a hormone called erythropoietin, produced in the kidneys, which then stimulates the bone marrow, causing the erythrocyte-forming cells to differentiate and divide and eventually form erythrocytes. Erythropoietin also causes the release of reticulocytes (immature red cells) into the circulation. The increased red cell mass then increases the amount of haemoglobin available to deliver oxygen and so the tissue oxygen level is increased. The sudden loss of a moderate amount of red cells through accident, or by donating a unit of blood, for example, is sufficient to stimulate the production of red cells to replace those lost. The heart pumps the blood around the body in the cardiovascular circulatory system, through the pulmonary (lungs) and systemic (body) circuits. The pumping of blood from the heart to the lungs allows the red cells to become oxygenated, and this oxygenated blood is then pumped to the brain and around the body via the arteries so that all parts of the body are reached. Once the blood reaches the tissues and delivers its oxygen and nutrients, the veins are then used to transport carbon dioxide back to the lungs for exhalation, and waste products to the kidneys and other organs for excretion. Figure 1·2 depicts a simplified circulatory system showing the major blood vessels and organs. The human body is far too complex to depict accurately in such a simplified form. This figure is intended to illustrate the positioning of major arteries and veins in relation to vital organs – all of which are reached by both arteries and veins. Simplified circulatory system showing major vessels and organs. The lymphatic system is part of the immune system, and is also a circulatory system because it transports fluids to the tissues of the body. It consists of a series of glands and vessels that collect interstitial fluid from tissue spaces and then transport it back again to the circulatory system. Arteries take oxygenated blood to the tissues; veins take deoxygenated blood back to the lungs. Where arteries meet veins there is an anastamosis. Figure 1·3 shows the direction of blood flow from artery to arteriole, arteriole to capillary and then capillary to venule and venule to vein. The anastamosis is found in the tissues, where the capillaries meet. Anastamosis between artery and vein. Blood is a suspension of various types of cells in a highly complex, aqueous (watery) material known as plasma. The volume of blood in the average healthy adult is about 5 l (7·7% of body mass). The pH is 7·3–7·4 which means that the degree of acidity-alkalinity is nearly neutral. Acidic fluids have a pH of less than 7·0 and alkaline fluids have a pH of more than 7·0. The specific gravity (SG) of blood is 1·050–1·065, which indicates that it is slightly heavier than pure water, which has an SG of 1·000. The two major portions of blood are plasma, which, in healthy individuals, is approximately 60% of the total volume, and cellular elements or blood cells, which account for the remaining 40%. About 90% of plasma consists of water. Plasma is a light yellow or straw coloured fluid. Many substances are dissolved in the plasma, including oxygen, carbon dioxide, nitrogen, electrolytes (such as sodium, chloride and potassium), proteins, hormones, lipids, carbohydrates, amino acids, vitamins and nitrogenous wastes such as urea and uric acid. Water is the solvent in which these substances are dissolved. There are many different proteins in plasma. These may be divided into two groups: albumin and globulin (clotting factors, enzymes and immunoglobulins). Total serum protein is 60–80 g/L and about half of this is composed of albumin, which is synthesized in the liver. As protein does not freely diffuse through intact vascular endothelium (blood vessel lining), it provides osmotic pressure that regulates the passage of water and diffusible solutes through the capillary walls. This means that fluid does not readily diffuse out of the vascular system into the tissues, but is retained in the circulation where it is needed. Albumin also serves as a carrier protein for various substances such as unconjugated bilirubin (the waste product of haemoglobin). After albumin, the most plentiful plasma proteins are the immunoglobulins (antibodies) of which five main classes have been recognized: immunoglobulin M (IgM), immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin D (IgD) and immunoglobulin E (IgE). These all serve in one way or another to protect the host from infection. Plasma is a transportation system for the following: Cellular elements – red cells, white cells and platelets. Oxygen is carried by the red cells from the lungs to the tissues. Carbon dioxide is carried, mainly by the red cells, from the tissues back to the lungs. Hormones, antibodies, coagulation factors and other substances are taken from the site of their production to the site where they are needed. Nutrients are absorbed into the bloodstream from the digestive system and taken to the tissues. Waste products from tissue metabolism are transported to the organs of excretion (e.g. kidneys). Main constituents of plasma (remembering that 90% of plasma is water): (1) Solids plasma proteins: albumin, globulin, fibrinogen regulatory proteins: enzymes, hormones, antibodies (2) Inorganic substances calcium bicarbonate sodium chloride iodine iron (3) Organic substances nutrients: sugars, amino acids and fats waste products: urea, uric acid and creatinine (4) Gases oxygen carbon dioxide. The blood cells, or formed elements, constitute approximately 40% of total blood volume in healthy individuals. They are divided into three main groups: Red cells (erythrocytes) White cells (leucocytes) Platelets (thrombocytes) Figure 1·4 shows a stained blood smear on a slide, viewed microscopically. Stained blood film showing red cells, white cells and platelets. Blood counts are done in the laboratory to estimate the numbers of cells in a patient, to determine whether or not these numbers fall within normal limits. For example, there are approximately 5 million red cells per cubic millimetre in normal adults. This result may be written in many different ways, all with the same interpretation: Five million cells per cubic millimetre = 5 million cells/mm3 Five million cells per cubic millimetre = 5 × 106/mm3 Five million cells per microlitre = 5 million cells/µl Five trillion cells per litre = 5 × 1012/l To ensure standardization, the system of SI units has been adopted by many countries. SI stands for Le Système international d’unités. This translates from the French as the International System of Units, and is the system of measurement most widely used in science today. It is a dynamic set of standards that may be changed only by international agreement, as the technology of measurement progresses. The white cells and platelets form the ‘buffy’ coat or layer, which is seen between the red cells and the plasma in anticoagulated blood samples that have been centrifuged. Figure 1·5 shows a centrifuged test tube of anticoagulated blood. Centrifuged test tube of anticoagulated blood. Red cells are described as non-nucleated, biconcave discs with a characteristic red colour as a result of a pigment contained in their haemoglobin. Oxygenated blood is bright red; deoxygenated blood loses its bright red colour and becomes dull, dark red. Haemoglobin consists of four closely linked polypeptide chains (globin), each of which is attached to an iron-containing complex (haem). The molecular mass of haemoglobin is about 68 000 Da. The haem is the part of the molecule responsible for its oxygen carrying capability. The major function of red cells is to transport oxygen from the lungs to the tissues for use in cellular respiration. The red cells also remove carbon dioxide from the tissues for excretion via the lungs during exhalation. The normal in vivo (in vivo is Latin for ‘in the body’) survival of red cells is 100–120 days. In vitro (in vitro means ‘within the glass’ or what is now known as ‘in the test tube’ and relates to being outside the body) survival depends on storage conditions and the type of anticoagulant and preserving fluid used. For a unit of donated blood, there should be sufficient viable cells at the end of the shelf life of that donation, for approximately 75% of the red cells still to be detectable in the bloodstream of the recipient, 24 hours after transfusion. White cells are responsible for host defence and for protecting the body from infection. There are many different kinds of white cells. They are nucleated cells, some of which are capable of independent movement and can change their shape to surround and then ingest or ‘swallow’ foreign matter such as bacteria. The process of removing potentially harmful agents in this manner is called phagocytosis. See Fig. 1·6 for an illustration of the process of phagocytosis. Other white cells produce immunoglobulins (antibodies) that react with the foreign matter, also with the intention to inactivate or make harmless, and remove from the circulation. Phagocytosis. Leucocytes are classified into three major groups: Monocytes Lymphocytes Granulocytes Each type of leucocyte has a distinct function and morphology. Monocytes are capable of ingesting bacteria and tissue debris or fragments by phagocytosis. They act as scavenger cells, clearing the body of foreign particles and the remains of cells, at the site of infection. Lymphocytes vary in size from small lymphocytes, which are slightly larger than red cells, to large lymphocytes, which are larger than monocytes. Lymphocytes are either T- or B- lymphocytes (also known as T cells or B cells). T-lymphocytes are involved in cellular immunity and have a regulatory role in humoral immunity. B-lymphocytes are responsible for humoral immunity that involves antibody production. Granulocytes are polymorphonuclear cells. They contain a nucleus which has three lobes. They are characterized by granules that are visible microscopically in the cytoplasm of the cells, after laboratory staining. Granulocytes fall into three subgroups: Neutrophils – main function is phagocytosis. Basophils – capable of phagocytosis and contain histamine and heparin. Eosinophils – capable of phagocytosis and are involved in allergic responses. Platelets are small particles that have no nucleus and come from the cytoplasm of bone marrow cells called megakaryocytes. They participate in blood coagulation. Platelets form a plug to seal damaged blood vessels and thus have a crucial role in haemostasis or the control of bleeding. Table 1·1 lists the normal blood measurements in adult men and women, Table 1·2 gives the normal lifespan of the formed elements in vivo and in vitro, and Table 1·3 notes the terms used to describe blood cells with abnormal counts. When the blood of an anaemic individual is examined, it is frequently found to have a raised level of immature red cells called reticulocytes. They are identifiable under the microscope by their remnants of cell nucleus. Although reticulocytes are also found in the bloodstream of healthy individuals, the level is raised in an anaemic state. Examples of red cell abnormalities leading to chronic anaemia, and which are of particular concern within the field of blood transfusion, include thalassaemia and sickle cell anaemia. This is an inherited disorder most commonly seen in individuals from areas of Asia and the Eastern Mediterranean. It is caused by a haemoglobin deficiency that leads to the red cells having a shortened lifespan. The disease may be mild to severe. Thalassaemia major is a more serious form of the disease than thalassaemia minor. Patients with thalassaemia major are severely anaemic and are often transfusion dependent. The disease causes enlargement of the liver and spleen, and bone expansion, as the body tries to compensate by expanding haemopoietic tissue into these areas. This is an inherited disorder first seen in the Arabian Peninsula, and parts of Asia and Africa. It is caused by structural defects within the haemoglobin molecule, which give rise to haemolysis. Individuals who inherit a double dose of the defective gene have red cells that change into a sickle or crescent shape during a sickle cell crisis. Sickle cells can become lodged in the capillaries; they also have a decreased lifespan. Most patients are asymptomatic most of the time and have red cells that appear to be of normal shape. Therefore they do not require routine transfusion. However, some patients require many blood transfusions throughout their life, and the disease can be very serious and complex to manage. Figure 1·7 shows a blood smear on a slide, with normal and sickle-shaped red blood cells as they appear under the microscope. Diagram showing sickle cells and normal red blood cells. Haemostasis is the term used to describe the control of bleeding, the formation of a clot, and in the time of healing, the resolution of the clot and a return to normal. The process has four major components: Vascular constriction occurs in a damaged blood vessel with a muscular wall. This means that the blood vessel contracts or tightens to minimize further loss of blood. Blood does not clot in the body because there is insufficient free thromboplastin. However, as a result of injury, thromboplastin is released and in the presence of calcium ions (Ca++), combines with prothrombin to form thrombin, which in turn activates platelets. Activated platelets amplify the response by activating more platelets, and fibrinogen stimulates their sticking together as a soft plug that loosely blocks the wound, dramatically slowing down the bleeding. Each clotting factor has in the meanwhile been participating in the process, which is why it is called the coagulation cascade. A mesh of insoluble fibrin is finally formed, resulting in a platelet plug and so reaching the endpoint of clot formation. As the clot shrinks a clear fluid called serum is exuded. The last component of the process is carried out by the enzyme plasmin, which is responsible for the gradual absorption of the clot by the body, so that a return to normal is eventually achieved. The coagulation of blood is a complex process initiated typically when the skin is breached. When normal levels of coagulation factors are present in the body, they act in a cascade, where one factor when activated, activates the next, and so on, until a clot is formed and bleeding is stopped (i.e. haemostasis is achieved). Each clotting factor has been assigned an individual Roman numeral as shown in Table 1·4. Blood coagulation is the culmination of a series of complex reactions that bring about a fibrin clot. The clotting cascade has two pathways; (i) the tissue factor pathway or (ii) the contact activation pathway. This is followed by a common pathway, in which clotting factor X, thrombin and fibrin are activated. Clotting factors circulate in the bloodstream in the form of inactive precursors. Table 1·5 shows a simplified coagulation cascade. The Roman numerals indicate the number of the clotting factor. The letter ‘a’ after a Roman numeral signifies that the clotting factor has been activated. With the exception of FV, FVIII and platelets, clotting factors are relatively stable in stored blood. Factor V and FVIII levels in donated blood plasma are stable only when frozen soon after collection to temperatures lower than –25°C. Platelet concentrates prepared from donated blood remain viable for up to 5 days under the correct conditions of storage: they need to be kept constantly in motion within a temperature range of +22°C ± 2°C. The process of coagulation is illustrated as a cascade in Fig. 1·8. Coagulation cascade. Life-threatening bleeding can occur as a result of defective haemostasis, which may be acquired or congenital. Acquired defects are those that develop in an otherwise normal and number of platelets in the body) as a result of transfusions of stored blood platelet deficiency of platelets, that do not function to the of of and to deficiency, caused by coagulation when the blood to clot in the body, a relatively condition that patients. defects are those that are inherited and present from and is inherited as a in which there is a of are of the men are and have a bleeding the of which from one individual to disease is inherited as a in which there is a of The signs and symptoms are very to A and laboratory may be to between the disease is seen in both men and and is inherited as an This means that it is not and because it is a can be inherited in a dose one There is a deficiency of FVIII and also of platelets. to be less than with Haemorrhage is the abnormal loss of large of blood as a result of or such as a loss of blood after of an When an individual loses more than of blood volume, normal for of the such as not be sufficient and the individual into which leads to blood as a result of the in blood Haemorrhage is the most common of which is characterized by the following: the because the blood to the is in to the vital organs. there is a in blood the heart than there is a in the excretion of Haemorrhage is not the only condition that is able to a state of Other causes are that shock of can be not reaching an shock occurs when there is a of as a result of of the blood vessels that the heart with shock is caused by the presence of with are so described because of the way they appear under the microscope after a process in the This type of or as a result of and this can to shock may be the result of a or to substances which the individual has formed an Haemopoiesis is the term used to describe the production of blood cells in the bone marrow. Erythropoiesis is the process of red cell production. Erythropoietin is a hormone that Because blood is transported in a system, it throughout the body, carrying oxygen from the lungs to the tissues, from the digestive system to the tissues where they are wastes from tissue metabolism to the organs of and substances needed to a healthy body, and and enzymes to body Blood plasma approximately 60% of the blood in healthy individuals, and 90% of this plasma is water. The consists of all the elements of the blood including albumin and The formed elements are the blood cells of the body, which include red cells, white cells and platelets. They form approximately 40% of the blood in healthy individuals. Red cells are responsible for oxygen to the tissues and carbon dioxide back to the lungs for exhalation. There are types of inherited red cell these include thalassaemia and sickle cell anaemia. White cells are responsible for body Monocytes are lymphocytes are either T or B cells that are responsible for cellular immunity or produce antibodies and the or polymorphonuclear cells have functions including phagocytosis. They are up of and the being involved in allergic responses. Platelets a vital role in blood coagulation. Haemostasis is the term used to describe coagulation or the of bleeding. A series of many different coagulation or clotting factors are to bleeding. Most of are stable in donated blood, but those that are include and A is an inherited disease caused by of factor B is an inherited disease caused by of factor disease is caused by a of factor and platelets. may be initiated by factors or This condition can be is (1) It is that use a the to the of and and to to the in this A of that may be in this is blood Blood cells Blood plasma Anaemia Blood circulation shock Blood coagulation (2) to whether or not there is a for patients with in the many patients have been with blood products available in the to patients with there in which the blood transfusion could its to patients with clotting The of this on Haematology has not from body within the The has no
Author: B. Armstrong
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4244635571
FWCI:
Cites:
Cited by:
Related to: 10